Prognostic Value of Left Ventricular 18 F-Florbetapir Uptake in Systemic Light-Chain Amyloidosis.

Olivier F Clerc Yesh DatarSarah Am CuddyGiada BianchiAlexandra TaylorDominik C BenzMatthew RobertsonMarie Foley KijewskiMichael Jerosch-Herold Raymond Y Kwong Frederick L Ruberg Ronglih Liao Marcelo F Di CarliRodney H FalkSharmila Dorbala

Published in: medRxiv : the preprint server for health sciences (2023)

F-florbetapir PET/CT to measure the effects of novel fibril-depleting therapies, in addition to plasma cell therapy, to improve outcomes in systemic AL amyloidosis.

Keyphrases

pet ct
cell therapy
left ventricular
stem cells
mesenchymal stem cells
positron emission tomography
multiple myeloma
heart failure
mitral valve
acute myocardial infarction
type diabetes
aortic stenosis
left atrial
metabolic syndrome
drug induced
insulin resistance
ejection fraction